|
|
Substance Withdrawal Syndrome - Psychology
Research News and Information
Definition of 'Substance Withdrawal Syndrome'Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Common names: Substance Withdrawal Syndrome; Substance Withdrawal Syndromes; Syndrome, Substance Withdrawal; Syndromes, Substance Withdrawal; Withdrawal Syndrome, Substance; Withdrawal Syndromes, Substance; Withdrawal Symptoms; Symptom, Withdrawal; Symptoms, Withdrawal; Withdrawal Symptom |
Saturday, November 21, 2009
Caffeine expectancy: instrument development in the Rasch measurement framework.
30 Aug 2009
Although caffeine is the most widely consumed psychoactive drug in the world, the mechanisms associated with consumption are not well understood. Nonetheless, outcome expectancies for caffeine use are thought to underlie caffeine's reinforcing ... Read more...
30 Aug 2009
The personality trait of sensation seeking has been positively associated with risk of smoking initiation and level of tobacco use. However, its role in smoking cessation is much less established. This study examined the association between ... Read more...
30 Jul 2009
OBJECTIVE: Prior efforts to assess the impact of antidepressant use on risk of suicide attempt focused on antidepressant initiation or duration of use. Gaps remain in understanding risks associated with antidepressant discontinuation in the context ... Read more...
Latest indexed articles for 'Substance Withdrawal Syndrome - Psychology'
These are the very latest articles for this heading:
- Caffeine expectancy: instrument development in the Rasch measurement framework.
30 Aug 2009 - Sensation seeking as a predictor of treatment compliance and smoking cessation treatment outcomes in heavy social drinkers.
30 Aug 2009 - Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study.
30 Jul 2009 - Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.
30 Jul 2009 - Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.
30 Jul 2009 - A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
30 Jul 2009 - Stress and addiction: a dynamic interplay of genes, environment, and drug intake.
13 Jul 2009 - Drug withdrawal after successful epilepsy surgery: how safe is it?
7 Jul 2009 - Relations between anhedonia and smoking motivation.
29 Jun 2009 - A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse.
29 Jun 2009 - Delusional parasitosis following heroin withdrawal: a case report.
29 Jun 2009 - Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice.
23 Jun 2009 - Measurement of affective state during chronic nicotine treatment and withdrawal by affective taste reactivity in mice: the role of endocannabinoids.
19 Jun 2009 - Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.
2 Jun 2009 - Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
Jun 2009 - Smokers' expectancies for abstinence: preliminary results from focus groups.
30 May 2009 - Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.
30 May 2009 - Anxiety sensitivity, acute nicotine withdrawal symptoms, and anxious and fearful responding to bodily sensations: a laboratory test.
30 May 2009 - A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms.
28 May 2009 - A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
24 May 2009
See a longer list of these articles.
Technical information about 'Substance Withdrawal Syndrome'
Definition: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Descriptor UI: D013375
Alternative terms: Substance Withdrawal Syndrome; Substance Withdrawal Syndromes; Syndrome, Substance Withdrawal; Syndromes, Substance Withdrawal; Withdrawal Syndrome, Substance; Withdrawal Syndromes, Substance; Withdrawal Symptoms; Symptom, Withdrawal; Symptoms, Withdrawal; Withdrawal Symptom; Drug Withdrawal Symptoms; Drug Withdrawal Symptom; Symptom, Drug Withdrawal; Symptoms, Drug Withdrawal; Withdrawal Symptom, Drug; Withdrawal Symptoms, Drug;
Allowable Qualifiers: blood; cerebrospinal fluid; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;
Tree Number: C21.739.835; F03.900.825;
Online Note: use SUBSTANCE WITHDRAWAL SYNDROME to search DRUG WITHDRAWAL SYMPTOMS 1966-80 (as Prov 1966)
History Note: 81; was DRUG WITHDRAWAL SYMPTOMS 1964-80 (Prov 1964-66)
Technical Notes: includes withdrawal from addictive drugs or other substances, administered drugs, smoking & alcohol (but DELIRIUM TREMENS see ALCOHOL WITHDRAWAL DELIRIUM is also available); do not use /compl for the symptom; coord IM with specific substance /adv eff (IM) + specific dis or symptom following withdrawal /chem ind (IM), e.g., hypertension after propranolol withdrawal = SUBSTANCE WITHDRAWAL SYNDROME (IM) + PROPRANOLOL /adv eff (IM) + HYPERTENSION /chem ind (IM); babies born to addicted mothers & developing withdraw symp = NEONATAL ABSTINENCE SYNDROME: see note there